Sign up to save your podcasts
Or
Share Pre-Session Views
Share to email
Share to Facebook
Share to X
Share to email
Share to Facebook
Share to X
Or
Pre-Session Views
- Strategy | We are buyers of every dip in Memphis PharmaWe are buyers of every dip in Memphis Pharma
- RAYA/RACC | RAYA/RACC acquisition is now most likely to go through at RAYA’s revised price of EGP9.0/share, exactly at the midpoint of our previously communicated price range
- PHAR | EIPICO III delay extends visibility gap, rotation toward MPCI and RMDA
- AMOC | Shareholder rotation reflects profitability headwinds
- EGAL | Riding the aluminum wave
View all episodes
By Al Ahly Pharos- Strategy | We are buyers of every dip in Memphis PharmaWe are buyers of every dip in Memphis Pharma
- RAYA/RACC | RAYA/RACC acquisition is now most likely to go through at RAYA’s revised price of EGP9.0/share, exactly at the midpoint of our previously communicated price range
- PHAR | EIPICO III delay extends visibility gap, rotation toward MPCI and RMDA
- AMOC | Shareholder rotation reflects profitability headwinds
- EGAL | Riding the aluminum wave
More shows like Al Ahly Pharos
View all
We Study Billionaires - The Investor’s Podcast Network
3,370 Listeners
FT News Briefing
647 Listeners
The World in Brief from The Economist
1,078 Listeners
G.Talks - The Podcast for Dreamers
5 Listeners
EnterpriseAM | Egypt
4 Listeners